세계의 가상 생검 시장 : 대상 치료 영역별, 대상 암 유형별, 이미징 기술 유형별, 최종 사용자별, 지역별, 주요 기업별 업계 동향 및 예측(-2035년)

Virtual Biopsy Market by Target Therapeutic Area, Type of Cancer Targeted, Type of Imaging Technology, End Users, Geographical Regions and Leading Players: Industry Trends and Global Forecasts, till 2035

US $ 4,799 ￦ 6,684,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 9,748,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 14,762,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 25,069,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

가상 생검 시장

가상 생검 시장 규모는 2019년에 5억 3,000만 달러에 달했습니다. 이 시장은 예측 기간 동안 14.47%의 CAGR로 확대될 전망이며, 현재 7억 8,000만 달러에서 2035년에는 30억 2,000만 달러에 이를 것으로 예측되고 있습니다.

가상 생검 시장 기회는 다음 부문에 분포되어 있습니다.

대상 치료 영역

• 종양학적 질환
• 신경 질환
• 심혈관 질환
• 안과 질환
• 내분비 질환
• 소화기 질환
• 기타

대상암 유형

• 고형암
• 유방암
• 폐암
• 전립선암
• 대장암
• 뇌종양
• 기타

이미징 기술 유형

• 자기 공명 영상법
• 컴퓨터 단층 촬영
• X선
• 초음파
• 기타

최종 사용자

• 자기 공명 영상
• 컴퓨터 단층 촬영
• X선
• 초음파
• 기타

지역

• 북미(미국, 캐나다)
• 유럽(독일, 프랑스, 이탈리아, 영국, 스페인, 스위스, 기타)
• 아시아태평양(중국, 일본, 인도, 한국, 호주 등)
• 중동 및 북아프리카(사우디아라비아, 이스라엘, 이집트, 기타)
• 라틴아메리카(브라질, 멕시코, 아르헨티나 등)

가상 생검 시장 : 성장 및 동향

수년 동안 헬스케어 전문가는 환자의 상태를 분석하기 위해 외과적으로 환자 샘플을 채취하는 기존의 생검 기술을 사용해 왔습니다. 그러나 이러한 방법은 감염, 절개 후 출혈, 불편함과 같은 여러 합병증이 수반되는 경우가 많습니다. 더불어 기존의 생검 기술은 샘플 채취, 외과적 개입, 수술실 유지 보수와 관련된 비용이 드는 경우가 많아 비용이 많이 듭니다.

인도의학연구평의회(ICMR)의 추정에 따르면 암 이환율은 2022년 140만 명에서 2025년에는 150만 명으로 증가할 것으로 예상되고 있습니다. 그 결과 질병의 발견과 환자의 케어를 강화하기 위해 보다 안전하고 효율적인 대체품에 대한 수요가 의료인들 사이에서 높아지고 있습니다.

증가하는 수요에 부응하여 기존의 기술과 관련된 건강 문제를 완화하기 위해 가상 생검 기술은 질병 감지 및 예후를 위한 비침습적 도구로 지지를 모으고 있습니다. 이 혁신적인 기술은 위험 경감이나 환자의 스크리닝 프로세스 개선 등 다양한 이점을 가져옵니다. 또한 가상 생검은 추출된 샘플의 이미지를 상세하게 분석하는 고급 인공지능(AI) 소프트웨어를 이용함으로써 환자의 상태에 대한 깊은 인사이트를 제공합니다. 게다가 이 접근법은 외과적 처치에 수반되는 리스크를 경감시키면서 치료 중의 약제 반응을 평가하는데 있어서 중요한 역할을 완수해, 치료 계획을 세우는데 필수적인 툴이 되고 있습니다.

가상 생검 기술의 기술적 진보와 효과적인 환자 관리 관리에 대한 수요가 증가함에 따라 가상 생검 기기의 채용은 꾸준히 증가하고 있으며, 헬스케어 분야에서 조기 발견과 일상적인 진단을 가능하게 할 것으로 예측됩니다.

가상 생검 시장 : 주요 인사이트

이 보고서는 가상 생검 시장의 현재 상태를 파악하고 업계 내 잠재적 성장 기회를 확인합니다. 본 보고서의 주요 조사 결과는 다음과 같습닌다. :

• 현재 세계 약 45개의 가상 생검 기기가 다양한 진출기업에 의해 개발되고 있으며, 이들 장치의 65%의 기술 혁신은 선진 지역에 본사를 두는 소규모 진출기업이 주도하고 있습니다.
• 자기 공명 화상법(33%)은 안전한 자기와 전파를 사용해 데이터를 취득하는 것으로부터, 화상 취득의 목적으로 가장 널리 채용되고 있는 기술로서 부상하고 있습니다.

• 거래의 50% 가까이가 지난 2년간 체결된 것으로, 이 사이에 파트너십 활동이 대폭 증가한 것을 나타내고 있습니다.
• 가상 생검 기술이 헬스케어의 성과를 개선하는데 있어서 여러가지 이점을 가지는 것으로부터, 많은 투자가가 기업에 자금 원조를 실시하고 있어, 2020년 이후 4억 2,500만 달러 이상이 투자되고 있습니다.
• 가상 생검과 관련된 약 85건의 특허가 이 분야에서 만들어진 지적 재산을 보호하기 위해 다양한 업계 및 비업계의 참가 기업에 의해 출원 및 부여되고 있습니다.

• 효율적인 헬스케어 툴의 개발에 공헌하는 최근의 기술 동향을 중심으로, 과학자별 65건 이상의 논문이 제출되고 있습니다.
• 가상 생검 시장은 기존의 생검 절차를 대체하는 보다 안전하고 효율적인 절차에 대한 수요가 높아짐에 따라 견인되고 있습니다만, 복잡한 규제 규범이 계속해서 업계 성장의 장벽이 되고 있습니다.
• 가상 생검과 관련된 시장 기회는 비침습적이고 보다 안전한 진단 툴에 대한 수요가 높아짐에 따라 2035년까지 연률 14.47%의 성장이 예상됩니다.

• 전반적인 시장 기회는 다양한 유형의 이미지 기술과 최종 사용자에게 잘 분배 될 것으로 예측됩니다.

가상 생검 시장 : 주요 부문

세계의 가상 생검 시장은 대상 치료 영역별로 종양성 질환, 신경질환, 심혈관질환, 안과질환, 내분비질환, 소화기질환 등으로 구분됩니다. 현재 가상 생검 시장의 대부분의 점유율을 차지하고 있는 것은 종양성 질환이며, 이는 암 진단에 있어서 가상 생검 장치와 같은 비침습적 장치에 대한 의사의 기호가 높아지고 있기 때문입니다. 이러한 장치는, 화상의 도입이나 데이터의 해석에 CT(컴퓨터 단층 촬영)나 MRI(자기 공명 화상)등의 첨단 기술을 이용하는 것으로, 이 수요의 고조에 대응하고 있습니다.

대상으로 하는 암 유형별로 세계의 가상 생검 시장은 고형 악성 종양, 유방암, 폐암, 전립선암, 대장암, 뇌종양, 기타에 분포하고 있습니다. 현재, 고형 악성 종양 분야가 시장 전체의 성장을 지배하고 견인할 전망입니다. 이것은 진단되는 성인 암 증례의 약 90%가 고형암이며, 그 결과, 이러한 질환을 효과적으로 진단할 수 있는 고도의 진단 장치에 대한 수요가 높아지고 있는 것에 기인하고 있습니다.

이미징 기술 유형별로는 세계의 가상 생검 시장은 자기 공명 영상, 컴퓨터 단층 촬영, X선, 초음파, 기타로 구분됩니다. 특히 자기 공명 이미징(MRI) 기술이 제공하는 샘플의 종합적인 360도 뷰를 포함한 다양한 이점으로 환자의 상태를 간단하고 효과적으로 분석할 수 있기 때문에 예측 기간 중 MRI 기술이 가상 생검 시장을 독점할 가능성이 높습니다.

최종 사용자별로 세계 시장은 병원 및 진료소, 연구기관 및 진단센터, 기타로 구분됩니다. 현재 병원 및 진료소 부문이 최대 시장 점유율을 차지하고 있습니다. 이는 병원이나 진료소에서 가상 생검 장치가 다양한 건강 상태의 스크리닝, 진단 및 예후 예측을 제공하기 때문에 수요가 증가하고 있기 때문입니다.

지역별로 볼 때 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동, 북아프리카로 구분됩니다. 현재 시나리오에서는 북미가 최대 시장 점유율을 차지할 가능성이 높습니다. 이것은, 이 지역의 헬스케어 영역에서 연구 개발 활동에 할당되는 예산액이 큰 것에 기인하고 있습니다. 그러나 라틴아메리카의 가상 생검 시장은 예측 기간 동안 더 높은 CAGR로 성장할 것으로 전망됩니다.

이 보고서에서 대답하는 주요 질문

• 현재, 이 시장에 참가하고 있는 기업은 몇사인가
• 이 시장의 주요 기업
• 이 시장의 진화에 영향을 줄 것 같은 요인
• 현재 및 미래 시장 규모
• 이 시장의 CAGR
• 현재 및 미래 시장 기회는 주요 시장 부문에 어떻게 분배될 것인가
• 업계 이해관계자가 일반적으로 채용하고 있는 제휴 모델은 어떤 것인가
• 현재 진행중인 투자 동향
• 이 시장에서의 특허 출원 동향

이 보고서를 구입하는 이유

• 이 보고서는 종합적인 시장 분석을 제공하며 시장 전체와 특정 하위 부문에 대한 자세한 수익 예측을 제공합니다. 이 정보는 이미 시장을 선도하고 있는 기업에 있어서도, 신규 참가 기업에 있어서도 귀중한 것입니다.
• 이해관계자는 시장 내 경쟁력학을 보다 깊이 이해하기 위해 보고서를 활용할 수 있습니다. 경쟁 상황을 분석함으로써 기업은 시장에서의 포지셔닝을 최적화하고 효과적인 시장 진입 전략을 개발하기 위해 정보에 입각한 의사결정을 할 수 있습니다.
• 이 보고서는 주요 촉진요인 및 시장 성장 억제요인과 과제 등 시장의 종합적인 개요를 이해관계자에게 제공합니다. 이 정보는 이해관계자가 시장 동향을 항상 파악하고 성장 전망을 활용하기 위한 데이터 주도의 의사결정을 하기 위한 힘이 됩니다.

기타 혜택

• PPT 인사이트 팩
• 보고서의 모든 분석 모듈의 무료 엑셀 데이터 팩
• 10% 무료 컨텐츠 커스터마이즈
• 조사팀에 의한 상세 보고서의 워크스루 세션
• 보고서가 6-12개월 이상 전인 경우, 무료 갱신 보고서

본 보고서에서는 세계의 가상 생검 시장에 대해 조사했으며, 시장 개요와 함께 대상 치료 영역별, 대상암 유형별, 이미징 기술 유형별, 최종 사용자별, 지역별, 주요 기업별 동향 및 시장 진출 기업 프로파일 등의 정보를 제공합니다.

목차

제1장 서문

제2장 조사 방법

제3장 시장 역학

제4장 거시경제지표

제5장 주요 요약

제6장 서문

• 장의 개요
• 가상 생검의 개요
• 기존 생검 및 가상 생검
• 가상 생검 실시 절차
• 가상 생검 용도
• 가상 생검에 따른 과제
• 장래의 전망

제7장 시장 상황

• 장의 개요
• 가상 생검 기기 : 시장 상황
• 가상 생검 기기 : 개발자의 상황

제8장 제품 경쟁력 분석

• 장의 개요
• 전제 및 주요 파라미터
• 조사 방법
• 제품 경쟁력 분석 : 가상 생검 기기

제9장 기업 프로파일 : 북미에 거점을 두는 개발업체

• 장의 개요
• GE HealthCare
• Imaging Biometrics
• OptoVibronex

제10장 기업 프로파일 : 유럽에 거점을 두는 개발업체

• 장의 개요
• ImageBiopsy Lab
• Median Technologies
• Quibim
• Siemens Healthineers

제11장 기업 프로파일 : 아시아태평양에 거점을 둔 가상 생검 제공업체

• 장의 개요
• City Imaging and Clinical Labs

제12장 파트너십 및 협업

제13장 자금 조달 및 투자

• 장의 개요
• 자금 조달 모델
• 가상 생검 : 자금 조달 및 투자
• 결론

제14장 특허 분석

제15장 출판물 분석

제16장 시장 영향 분석

• 장의 개요
• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 시장 과제
• 결론

제17장 가상 생검 시장

제18장 가상 생검 시장 : 대상 치료 영역별

제19장 가상 생검 시장 : 대상암 유형별

제20장 가상 생검 시장 : 이미징 기술 유형별

제21장 가상 생검 시장 : 최종 사용자별

제22장 가상 생검 시장 : 지역별

제23장 가상 생검 시장 : 주요 기업별

제24장 결론

제25장 주요 인사이트

제26장 부록 I : 표 형식 데이터

제27장 부록 II : 기업 및 조직 목록

AJY

영문 목차

영문목차

VIRTUAL BIOPSY MARKET

As per Roots Analysis, the virtual biopsy market, valued at USD 0.53 billion in 2019, is projected to reach USD 0.78 billion in current year and USD 3.02 billion by 2035, representing a CAGR of 14.47% during the forecast period.

The opportunity for virtual biopsy market has been distributed across the following segments:

Target Therapeutic Area

• Oncological Disorders
• Neurological Disorders
• Cardiovascular Disorders
• Ophthalmological Disorders
• Endocrine Disorders
• Gastrointestinal Disorders
• Others

Type of Cancer Targeted

• Solid Malignancies
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Brain Cancer
• Others

Type of Imaging Technology

• Magnetic Resonance Imaging
• Computed Tomography
• X-ray
• Ultrasound
• Others

End Users

• Magnetic Resonance Imaging
• Computed Tomography
• X-ray
• Ultrasound
• Others

Geographical Regions

• North America (US and Canada)
• Europe (Germany, France, Italy, UK, Spain, Switzerland and Rest of Europe)
• Asia-Pacific (China, Japan, India, South Korea, Australia and Rest of Asia-Pacific)
• Middle East and North Africa (Saudi Arabia, Israel, Egypt, and Rest of Middle East and North Africa)
• Latin America (Brazil, Mexico, Argentina and Rest of Latin America)

VIRTUAL BIOPSY MARKET: GROWTH AND TRENDS

Over the years, healthcare professionals have been using conventional biopsy techniques for extracting patient samples surgically in order to analyze their condition. However, these methods are often associated with several complications, such as infections, hemorrhage after incision, and patient discomfort. In addition, conventional biopsy techniques are often cost intensive, with expenses related to sample collection, surgical interventions and operating room maintenance.

Based on estimates by the Indian Council of Medical Research (ICMR), the incidence of cancer cases is expected to increase from 1.4 million in 2022 to 1.5 million by 2025. As a result, the demand for safer and more efficient alternatives is increasing among medical professionals to enhance disease detection and patient care.

In order to meet the growing demand and mitigate the health concerns associated with the convention procedures, the virtual biopsy technique has gained traction as a non-invasive tool for disease detection and prognosis. This innovative technique provides various benefits, including reduced risks and the improved patient screening process. Further, virtual biopsy offers in-depth insights into patients' conditions by utilizing advanced artificial intelligence (AI) software that analyzes images from extracted samples in detail. Additionally, this approach plays a critical role in evaluating drug responses during treatment while mitigating the risks associated with surgical procedures, making it an essential tool for planning treatment.

Driven by the technological advancements in virtual biopsy techniques and the rising demand for effective patient care management, the adoption of virtual biopsy devices is steadily increasing and is anticipated to enable early detection and routine diagnostics in the healthcare sector.

VIRTUAL BIOPSY MARKET: KEY INSIGHTS

The report delves into the current state of the virtual biopsy market and identifies potential growth opportunities within the industry. Some key findings from the report include:

• Presently, about 45 virtual biopsy devices are being developed by various players worldwide; the innovation for 65% of these devices is being led by small players headquartered in developed regions.
• Magnetic resonance imaging (33%) has emerged as the most widely employed technology for image acquisition purposes, owing to the fact that it uses safe magnetic and radio waves for capturing data.

• Close to 50% of the deals have been inked in the last two years, demonstrating a considerable increase in partnership activity during this period; of these, more than 65% of the partnerships were international deals.
• Given the various benefits of virtual biopsy techniques in improving healthcare outcomes, a significant number of investors have provided financial support to the companies; over USD 425 million has been invested since 2020.
• Around 85 patents related to virtual biopsy have been filed / granted by various industry and non-industry players to protect the intellectual property generated within this field.

• More than 65 publications have been filed by scientists, focusing on recent technological advancements that contribute to the development of efficient healthcare tools.
• The virtual biopsy market is driven by an increase in the demand for safer and more efficient alternatives to conventional biopsy procedures; however, complex regulatory norms continue to pose a barrier to the industry growth.
• The market opportunity associated with virtual biopsy is likely to witness an annualized growth rate of 14.47% till 2035, owing to the growing demand for non-invasive and safer diagnostic tools.

• The overall opportunity is expected to be well distributed across different types of imaging technologies and end users.

VIRTUAL BIOPSY MARKET: KEY SEGMENTS

Oncological Disorder Segment is Likely to Dominate the Virtual Biopsy Market During the Forecast Period

Based on the target therapeutic area, the global market for virtual biopsy is segmented into oncological disorders, neurological disorders, cardiovascular disorders, ophthalmological disorders, endocrine disorders, gastrointestinal disorders and others. Currently, the majority share of the virtual biopsy market is captured by oncological disorders driven by the growing preference of physicians for non-invasive devices, such as virtual biopsy devices in cancer diagnosis. These devices meet this rising demand by using advanced technologies, such as computed tomography and magnetic resonance imaging for image capturing and analyzing the data.

Solid Malignancies Segment is Likely to Hold the Largest Share of the Virtual Biopsy Market During the Forecast Period

Based on the type of cancer targeted, the global virtual biopsy market is distributed across solid malignancies, breast cancer, lung cancer, prostate cancer, colorectal cancer, brain cancer and others. Currently, the solid malignancies segment is likely to dominate and drive the overall market growth. This can be attributed to the fact that solid tumors account for around 90% of all the adult cancer cases diagnosed, which results in increased demand for advanced diagnostic devices that can effectively diagnose such disorders.

By Type of Imaging Technology, Virtual Biopsy Devices Utilizing Magnetic Resonance Imaging Technology are Likely to Dominate the Market During the Forecast Period

Based on the type of imaging technology, the global virtual biopsy market is segmented across magnetic resonance imaging, computed tomography, X-ray, ultrasound and others. Notably, owing to the various advantages offered by magnetic resonance imaging (MRI) technology including a comprehensive 360-degree view of the sample, enabling easy and effective analysis of patient's condition, it is likely to dominate the virtual biopsy market during the forecast period.

Currently, Hospitals and Clinics Segment Holds the Largest Share of the Virtual Biopsy Market

Based on end users, the global market is segmented into hospitals and clinics, research institutions and diagnostic centers, and others. Currently, the hospitals and clinics segment holds the largest market share. This can be attributed to the increased demand for virtual biopsy devices in hospitals and clinics as these devices provide screening, diagnosis, and prognosis for various health conditions in these settings.

North America Accounts for the Largest Share of the Market

Based on geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa. In the current scenario, North America is likely to capture the largest market share. This can be attributed to the substantial budget amount allotted for research and development activities in the healthcare domain in this region. However, the virtual biopsy market in Latin America is expected to grow at a higher CAGR during the forecast period.

EXAMPLE PLAYERS IN THE VIRTUAL BIOPSY MARKET

• GE Healthcare
• Imaging Biometrics
• OptoVibronex
• ImageBiopsy Lab
• Median Technologies
• Quibim
• Siemens Healthineers
• City Imaging and Clinical Labs

VIRTUAL BIOPSY MARKET: RESEARCH COVERAGE

The report on the virtual biopsy market features insights on various sections, including:

• Market Sizing and Opportunity Analysis: An in-depth analysis of the virtual biopsy market, focusing on key market segments, including [A] target therapeutic area, [B] type of cancer targeted, [C] type of imaging technology, [D] end users, [E] geographical regions and [F] leading players.
• Market Impact Analysis: A thorough analysis of various factors, such as drivers, restraints, opportunities, and existing challenges that are likely to impact market growth.
• Virtual Biopsy Devices Market Landscape: A comprehensive evaluation of various virtual biopsy devices, based on several relevant parameters, such as [A] status of development, [B] year of approval, [C] region of approval, [D] regulatory accreditations, [E] type of step involved, [F] clinical purpose, [G] type of imaging technology used, [H] therapeutic application, [I] target therapeutic area, and [J] type of cancer targeted. This section also features a list of players engaged in the development of virtual biopsy devices, along with analyses based on [A] year of establishment, [B] company size, [C] location of headquarters and [D] most active developers.
• Company Profiles: Detailed profiles of companies engaged in developing virtual biopsy devices across various regions, including [A] company overview, [B] financial information (if available), [C] virtual biopsy device portfolio, [D] recent developments and [E] an informed future outlook.
• Product Competitiveness Analysis: An in-depth analyses of virtual biopsy devices, based on various relevant parameters, such as [A] company strength, [B] product portfolio strength and [C] product portfolio diversity.
• Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in virtual biopsy domain, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of partner, [D] type of imaging technology used, [E] therapeutic application, [F] most active players, and [G] geographical distribution of partnership activity.
• Funding and Investments: An in-depth analysis of the funding raised by companies engaged in the virtual biopsy domain, based on relevant parameters, such as [A] year of funding, [B] type of funding, [C] amount invested, [D] geographical distribution, [E] most active players and [F] most active investors.
• Patent Analysis: Detailed analysis of patents filed / granted till date in the virtual biopsy domain, based on various relevant parameters, such as [A] type of patent, [B] publication year, [B] application year, [C] CPC symbols, [D] patent jurisdiction, [E] type of applicant, [F] leading industry players, [G] patent benchmarking, [H] patent valuation analysis, and [I] leading patents.
• Publication Analysis: A comprehensive assessment of publications made in the virtual biopsy domain, based on various relevant parameters, such as [A] year of publication, [B] type of publication, [C] key copyright holders, [D] most active publishers, [E] most active publishers (in terms of number of publications and impact factor) and [F] most popular keywords used.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?
• What kind of partnership models are commonly adopted by industry stakeholders?
• What is the ongoing investment trend in this market?
• What is the patent filing activity trend in the market?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 10% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Introduction
• 1.2. Market Share Insights
• 1.3. Key Market Insights
• 1.4. Report Coverage
• 1.5. Key Questions Answered
• 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

• 2.1. Chapter Overview
• 2.2. Research Assumptions
  • 2.2.1. Market Landscape and Market Trends
  • 2.2.2. Market Forecast and Opportunity Analysis
  • 2.2.3. Comparative Analysis
• 2.3. Database Building
  • 2.3.1. Data Collection
  • 2.3.2. Data Validation
  • 2.3.3. Data Analysis
• 2.4. Project Methodology
  • 2.4.1. Secondary Research
    • 2.4.1.1. Annual Reports
    • 2.4.1.2. Academic Research Papers
    • 2.4.1.3. Company Websites
    • 2.4.1.4. Investor Presentations
    • 2.4.1.5. Regulatory Filings
    • 2.4.1.6. White Papers
    • 2.4.1.7. Industry Publications
    • 2.4.1.8. Conferences and Seminars
    • 2.4.1.9. Government Portals
    • 2.4.1.10. Media and Press Releases
    • 2.4.1.11. Newsletters
    • 2.4.1.12. Industry Databases
    • 2.4.1.13. Roots Proprietary Databases
    • 2.4.1.14. Paid Databases and Sources
    • 2.4.1.15. Social Media Portals
    • 2.4.1.16. Other Secondary Sources
  • 2.4.2. Primary Research
    • 2.4.2.1. Types of Primary Research
      • 2.4.2.1.1. Qualitative Research
      • 2.4.2.1.2. Quantitative Research
      • 2.4.2.1.3. Hybrid Approach
    • 2.4.2.2. Advantages of Primary Research
    • 2.4.2.3. Techniques for Primary Research
      • 2.4.2.3.1. Interviews
      • 2.4.2.3.2. Surveys
      • 2.4.2.3.3. Focus Groups
      • 2.4.2.3.4. Observational Research
      • 2.4.2.3.5. Social Media Interactions
    • 2.4.2.4. Key Opinion Leaders Considered in Primary Research
      • 2.4.2.4.1. Company Executives (CXOs)
      • 2.4.2.4.2. Board of Directors
      • 2.4.2.4.3. Company Presidents and Vice Presidents
      • 2.4.2.4.4. Research and Development Heads
      • 2.4.2.4.5. Technical Experts
      • 2.4.2.4.6. Subject Matter Experts
      • 2.4.2.4.7. Scientists
      • 2.4.2.4.8. Doctors and Other Healthcare Providers
    • 2.4.2.5. Ethics and Integrity
      • 2.4.2.5.1. Research Ethics
      • 2.4.2.5.2. Data Integrity
  • 2.4.3. Analytical Tools and Databases
• 2.5. Robust Quality Control

3. MARKET DYNAMICS

• 3.1. Chapter Overview
• 3.2. Forecast Methodology
  • 3.2.1. Top-down Approach
  • 3.2.2. Bottom-up Approach
  • 3.2.3. Hybrid Approach
• 3.3. Market Assessment Framework
  • 3.3.1. Total Addressable Market (TAM)
  • 3.3.2. Serviceable Addressable Market (SAM)
  • 3.3.3. Serviceable Obtainable Market (SOM)
  • 3.3.4. Currently Acquired Market (CAM)
• 3.4. Forecasting Tools and Techniques
  • 3.4.1. Qualitative Forecasting
  • 3.4.2. Correlation
  • 3.4.3. Regression
  • 3.4.4. Extrapolation
  • 3.4.5. Convergence
  • 3.4.6. Sensitivity Analysis
  • 3.4.7. Scenario Planning
  • 3.4.8. Data Visualization
  • 3.4.9. Time Series Analysis
  • 3.4.10. Forecast Error Analysis
• 3.5. Key Considerations
  • 3.5.1. Demographics
  • 3.5.2. Government Regulations
  • 3.5.3. Reimbursement Scenarios
  • 3.5.4. Market Access
  • 3.5.5. Supply Chain
  • 3.5.6. Industry Consolidation
  • 3.5.7. Pandemic / Unforeseen Disruptions Impact
• 3.6. Limitations

4. MACRO-ECONOMIC INDICATORS

• 4.1. Chapter Overview
• 4.2. Market Dynamics
  • 4.2.1. Time Period
    • 4.2.1.1. Historical Trends
    • 4.2.1.2. Current and Forecasted Estimates
  • 4.2.2. Currency Coverage
    • 4.2.2.1. Major Currencies Affecting the Market
    • 4.2.2.2. Factors Affecting Currency Fluctuations
    • 4.2.2.3. Impact of Currency Fluctuations on the Industry
  • 4.2.3. Foreign Currency Exchange Rate
    • 4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
    • 4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
  • 4.2.4. Recession
    • 4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
  • 4.2.5. Inflation
    • 4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
    • 4.2.5.2. Potential Impact of Inflation on the Market Evolution
  • 4.2.6. Interest Rates
    • 4.2.6.1. Interest Rates and Their Impact on the Market
    • 4.2.6.2. Strategies for Managing Interest Rate Risk
  • 4.2.7. Commodity Flow Analysis
    • 4.2.7.1. Type of Commodity
    • 4.2.7.2. Origins and Destinations
    • 4.2.7.3. Values and Weights
    • 4.2.7.4. Modes of Transportation
  • 4.2.8. Global Trade Dynamics
    • 4.2.8.1. Import Scenario
    • 4.2.8.2. Export Scenario
    • 4.2.8.3. Trade Policies
    • 4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
    • 4.2.8.5. Impact of Trade Barriers on the Market
  • 4.2.9. War Impact Analysis
    • 4.2.9.1. Russian-Ukraine War
    • 4.2.9.2. Israel-Hamas War
  • 4.2.10. COVID Impact / Related Factors
    • 4.2.10.1. Global Economic Impact
    • 4.2.10.2. Industry-specific Impact
    • 4.2.10.3. Government Response and Stimulus Measures
    • 4.2.10.4. Future Outlook and Adaptation Strategies
  • 4.2.11. Other Indicators
    • 4.2.11.1. Fiscal Policy
    • 4.2.11.2. Consumer Spending
    • 4.2.11.3. Gross Domestic Product (GDP)
    • 4.2.11.4. Employment
    • 4.2.11.5. Taxes
    • 4.2.11.6. Stock Market Performance
    • 4.2.11.7. Cross-Border Dynamics
• 4.3. Conclusion

5. EXECUTIVE SUMMARY

6. INTRODUCTION

• 6.1. Chapter Overview
• 6.2. Overview of Virtual Biopsy
• 6.3. Conventional Biopsy Versus Virtual Biopsy
• 6.4. Steps Involved in Performing Virtual Biopsy
  • 6.4.1. Acquisition of Data
  • 6.4.2. Data Harmonization
  • 6.4.3. Division of Data
  • 6.4.4. Region of Interests (ROI) Segmentation
  • 6.4.5. Extraction and Selection of Image Features
  • 6.4.6. Validation of Model
• 6.5. Applications of Virtual Biopsy
  • 6.5.1. Cancer Management
  • 6.5.2. Other Therapeutic Applications
• 6.6. Challenges Associated with Virtual Biopsy
• 6.7. Future Perspectives

7. MARKET LANDSCAPE

• 7.1. Chapter Overview
• 7.2. Virtual Biopsy Devices: Overall Market Landscape
  • 7.2.1. Analysis by Status of Development
  • 7.2.2. Analysis by Year of Approval
  • 7.2.3. Analysis by Region of Approval
  • 7.2.4. Analysis by Regulatory Accreditations
  • 7.2.5. Analysis by Type of Step Involved
  • 7.2.6. Analysis by Clinical Purpose
  • 7.2.7. Analysis by Type of Imaging Technology Used
  • 7.2.8. Analysis by Status of Development and Type of Imaging Technology Used
  • 7.2.9. Analysis by Therapeutic Application
  • 7.2.10. Analysis by Target Therapeutic Area
  • 7.2.11. Analysis by Status of Development and Target Therapeutic Area
  • 7.2.12. Analysis by Type of Cancer Targeted
• 7.3. Virtual Biopsy Devices: Developer Landscape
  • 7.3.1. Analysis by Year of Establishment
  • 7.3.2. Analysis by Company Size
  • 7.3.3. Analysis by Location of Headquarters (Region)
  • 7.3.4. Analysis by Status of Development and Location of Headquarters (Region)
  • 7.3.5. Analysis by Location of Headquarters (Country)
  • 7.3.6. Analysis by Company Size and Location of Headquarters (Region)
  • 7.3.7. Most Active Developers: Analysis by Number of Virtual Biopsy Devices Developed

8. PRODUCT COMPETITIVENESS ANALYSIS

• 8.1. Chapter Overview
• 8.2. Assumptions and Key Parameters
• 8.3. Methodology
• 8.4. Product Competitiveness Analysis: Virtual Biopsy Devices
  • 8.4.1. Product Competitiveness Analysis: Virtual Biopsy Devices Developed by Players based in North America
  • 8.4.2. Product Competitiveness Analysis: Virtual Biopsy Devices Developed by Players based in Europe and Asia-Pacific

9. COMPANY PROFILES: DEVELOPERS BASED IN NORTH AMERICA

• 9.1. Chapter Overview
• 9.2. GE HealthCare
  • 9.2.1. Company Overview
  • 9.2.2. Financial Information
  • 9.2.3. Virtual Biopsy Device Portfolio
  • 9.2.4. Recent Developments and Future Outlook
• 9.3. Imaging Biometrics
• 9.4. OptoVibronex

10. COMPANY PROFILES: DEVELOPERS BASED IN EUROPE

• 10.1. Chapter Overview
• 10.2. ImageBiopsy Lab
  • 10.2.1. Company Overview
  • 10.2.2. Virtual Biopsy Device Portfolio
  • 10.2.3. Recent Developments and Future Outlook
• 10.3. Median Technologies
• 10.4. Quibim
• 10.5. Siemens Healthineers

11. COMPANY PROFILES: VIRTUAL BIOPSY PROVIDERS BASED IN ASIA-PACIFIC

• 11.1. Chapter Overview
• 11.2. City Imaging and Clinical Labs
  • 11.2.1. Company Overview
  • 11.2.2. Virtual Biopsy Device Portfolio
  • 11.2.3. Recent Developments and Future Outlook

12. PARTNERSHIPS AND COLLABORATIONS

• 12.1. Chapter Overview
• 12.2. Partnership Models
• 12.3. Virtual Biopsy: Partnerships and Collaborations
  • 12.3.1. Analysis by Year of Partnership
  • 12.3.2. Analysis by Type of Partnership
  • 12.3.3. Analysis by Year and Type of Partnership
  • 12.3.4. Analysis by Type of Partner
  • 12.3.5. Analysis by Type of Imaging Technology
  • 12.3.6. Analysis by Therapeutic Application
  • 12.3.7. Most Active Players: Analysis by Number of Partnerships
  • 12.3.8. Analysis by Geography
    • 12.3.8.1. Local and International Agreements
    • 12.3.8.2. Intracontinental and Intercontinental Agreements

13. FUNDING AND INVESTMENTS

• 13.1. Chapter Overview
• 13.2. Funding Models
• 13.3. Virtual Biopsy: Funding and Investments
  • 13.3.1. Analysis by Year of Funding
  • 13.3.2. Analysis by Type of Funding
  • 13.3.3. Analysis by Year and Type of Funding
  • 13.3.4. Analysis by Amount Invested
  • 13.3.5. Analysis of Amount Invested by Type of Funding
  • 13.3.6. Analysis by Geography
  • 13.3.7. Most Active Players: Analysis by Number of Funding Instances
  • 13.3.8. Most Active Players: Analysis by Amount Raised
  • 13.3.9. Leading Investors: Analysis by Number of Funding Instances
• 13.4. Concluding Remarks

14. PATENT ANALYSIS

• 14.1. Chapter Overview
• 14.2. Scope And Methodology
• 14.3. Virtual Biopsy: Patent Analysis
  • 14.3.1. Analysis by Patent Publication Year
  • 14.3.2. Analysis by Type of Patent and Publication Year
  • 14.3.3. Analysis by Patent Application Year
  • 14.3.4. Analysis by Patent Jurisdiction
  • 14.3.5. Analysis by CPC Symbols
  • 14.3.6. Analysis by Type of Applicant
  • 14.3.7. Leading Industry Players: Analysis by Number of Patents
  • 14.3.8. Leading Non-Industry Players: Analysis by Number of Patents
• 14.4. Patent Benchmarking Analysis
  • 14.4.1. Analysis by Patent Characteristics (CPC Codes) by Leading Industry Players
• 14.5. Patent Valuation
• 14.6. Leading Patents by Number of Citations

15. PUBLICATION ANALYSIS

• 15.1. Chapter Overview
• 15.2. Scope and Methodology
• 15.3. Virtual Biopsy: Publication Analysis
  • 15.3.1. Analysis by Year of Publication
  • 15.3.2. Analysis by Type of Publication
  • 15.3.3. Key Copyright Holders: Analysis by Number of Publications
  • 15.3.4. Most Active Publishers: Analysis by Number of Publications
  • 15.3.5. Key Journals: Analysis by Number of Publications
  • 15.3.6. Key Journals: Analysis by Impact Factor
  • 15.3.7. Publication Analysis: Most Popular Keywords

16. MARKET IMPACT ANALYSIS

• 16.1. Chapter Overview
• 16.2. Market Drivers
• 16.3. Market Restraints
• 16.4. Market Opportunities
• 16.5. Market Challenges
• 16.6. Conclusion

17. VIRTUAL BIOPSY MARKET

• 17.1. Chapter Overview
• 17.2. Key Assumptions and Methodology
• 17.3. Global Virtual Biopsy Market, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 17.3.1. Scenario Analysis
    • 17.3.1.1. Conservative Scenario
    • 17.3.1.2. Optimistic Scenario
• 17.4. Key Market Segmentations

18. VIRTUAL BIOPSY MARKET, BY TARGET THERAPEUTIC AREA

• 18.1. Chapter Overview
• 18.2. Key Assumptions and Methodology
• 18.3. Virtual Biopsy Market: Distribution by Target Therapeutic Area
  • 18.3.1. Virtual Biopsy Market for Oncological Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 18.3.2. Virtual Biopsy Market for Neurological Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 18.3.3. Virtual Biopsy Market for Cardiovascular Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 18.3.4. Virtual Biopsy Market for Ophthalmological Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 18.3.5. Virtual Biopsy Market for Endocrine Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 18.3.6. Virtual Biopsy Market for Gastrointestinal Disorders, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 18.3.7. Virtual Biopsy Market for Others, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

19. VIRTUAL BIOPSY MARKET, BY TYPE OF CANCER TARGETED

• 19.1. Chapter Overview
• 19.2. Key Assumptions and Methodology
• 19.3. Virtual Biopsy Market: Distribution by Type of Cancer Targeted
  • 19.3.1. Virtual Biopsy Market for Solid Malignancies, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 19.3.2. Virtual Biopsy Market for Breast Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 19.3.3. Virtual Biopsy Market for Lung Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 19.3.4. Virtual Biopsy Market for Prostate Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 19.3.5. Virtual Biopsy Market for Colorectal Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 19.3.6. Virtual Biopsy Market for Brain Cancer, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 19.3.7. Virtual Biopsy Market for Others, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
• 19.4. Data Triangulation and Validation

20. VIRTUAL BIOPSY MARKET, BY TYPE OF IMAGING TECHNOLOGY

• 20.1. Chapter Overview
• 20.2. Key Assumptions and Methodology
• 20.3. Virtual Biopsy Market: Distribution by Type of Imaging Technology
  • 20.3.1. Virtual Biopsy Market for Magnetic Resonance Imaging, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 20.3.2. Virtual Biopsy Market for Computed Tomography, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 20.3.3. Virtual Biopsy Market for X-ray, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 20.3.4. Virtual Biopsy Market for Ultrasound, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 20.3.5. Virtual Biopsy Market for Others, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
• 20.4. Data Triangulation and Validation

21. VIRTUAL BIOPSY MARKET, BY END USERS

• 21.1. Chapter Overview
• 21.2. Key Assumptions and Methodology
• 21.3. Virtual Biopsy Market: Distribution by End Users
  • 21.3.1. Virtual Biopsy Market for Hospitals and Clinics, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 21.3.2. Virtual Biopsy Market for Research Institutes and Diagnostic Centers, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 21.3.3. Virtual Biopsy Market for Others, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
• 21.4. Data Triangulation and Validation

22. VIRTUAL BIOPSY MARKET, BY GEOGRAPHICAL REGIONS

• 22.1. Chapter Overview
• 22.2. Key Assumptions and Methodology
• 22.3. Virtual Biopsy Market: Distribution by Geographical Regions
  • 22.3.1. Virtual Biopsy Market for North America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.1.1. Virtual Biopsy Market in the US, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.1.2. Virtual Biopsy Market in Canada, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.1.3. Virtual Biopsy Market in Rest of North America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 22.3.2. Virtual Biopsy Market for Europe, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.2.1. Virtual Biopsy Market in Germany, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.2.2. Virtual Biopsy Market in France, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.2.3. Virtual Biopsy Market in Italy, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.2.4. Virtual Biopsy Market in Spain, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.2.5. Virtual Biopsy Market in the UK, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.2.6. Virtual Biopsy Market in Switzerland, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.2.7. Virtual Biopsy Market in Rest of Europe, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 22.3.3. Virtual Biopsy Market for Asia-Pacific, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.3.1. Virtual Biopsy Market in Japan, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.3.2. Virtual Biopsy Market in China, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.3.3. Virtual Biopsy Market in India, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.3.4. Virtual Biopsy Market in South Korea, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.3.5. Virtual Biopsy Market in Australia, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.3.6. Virtual Biopsy Market in Rest of Asia Pacific, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 22.3.4. Virtual Biopsy Market for Middle East and North Africa, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.4.1. Virtual Biopsy Market in Saudi Arabia, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.4.2. Virtual Biopsy Market in Egypt, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.4.3. Virtual Biopsy Market in Israel, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.4.4. Virtual Biopsy Market in Rest of Middle East and North Africa, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
  • 22.3.5. Virtual Biopsy Market for Latin America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.5.1. Virtual Biopsy Market in Brazil, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.5.2. Virtual Biopsy Market in Mexico, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.5.3. Virtual Biopsy Market in Argentina, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
    • 22.3.5.4. Virtual Biopsy Market in Rest of Latin America, Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
• 22.4. Virtual Biopsy Market by Geographical Regions: Market Dynamics Assessment
  • 22.4.1. Market Movement Analysis
  • 22.4.2. Penetration Growth (P-G) Matrix
• 22.5. Data Triangulation and Validation

23. VIRTUAL BIOPSY MARKET, LEADING PLAYERS

• 23.1. Chapter Overview
• 23.2. Key Assumptions and Methodology
• 23.3. Virtual Biopsy Market: Distribution by Leading Players
• 23.4. Data Triangulation and Validation

24. CONCLUDING REMARKS

25. EXECUTIVE INSIGHTS

26. APPENDIX I: TABULATED DATA

27. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION

관련자료